Refractory Angina Pectoris
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: - age 18 to 90 of either sex - mentally competent and able to fill in the questionnaires - implanted with an IPG capable of delivering both conventional and BurstDRTM SCS - no changes in anti-angina medication in the previous three months - no procedures like PCI or CABG, nor instability of the clinical signs and symptoms of refractory angina in the previous three months - the implanted SCS system has no signs of hardware problems (normal lead impedances) - able to use the remote control I pod
Exclusion criteria
Exclusion criteria: - signs of instable angina pectoris - unexplained weight loss in the previous three months - inability to visit the outpatient department for the follow-up visits - unable to provide informed consent - myocardial infarction or unstable angina in the previous three months
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Clinical effectiveness of the SCS treatment for refractory angina will be measured with the Seattle angina questionnaire (SAQ) comparing baseline conventional stimulation with burst SCS at 1 month. | — |
Secondary
| Measure | Time frame |
|---|---|
| Patient satisfaction will be measured on a 11 point Numeric Rating Scale and quality of life with the EQ5D. | — |
Countries
Netherlands